A targeted drug combination delays advanced prostate cancer in men with specific DNA repair gene mutations. A large international study led by researchers at UCL has found that a new combination of dr ...

Former President Joe Biden, who was diagnosed with an aggressive form of prostate cancer in May, completed a course of ...

“As part of a treatment plan for prostate cancer, President Biden is currently undergoing radiation therapy and hormone ...

A Biden spokeswoman confirmed the former president finished several weeks of radiation therapy treatment Monday.

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, ...

A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier.

Australia best in region for prostate cancer,but men's mental health at risk - new reportAustralian men live longer after a diagnosis of prostate ...

Outside prostate cancer, Truqap is FDA-approved with fulvestrant (Faslodex) for patients with hormone receptor-positive, HER2 ...

PluvictoTM plus standard of care (ARPI + ADT) significantly reduced risk of progression or death by 28% (HR 0.72) versus SoC alone, with positive trend in OS (HR 0.84) in PSMA+ metastatic ...

Novartis has shared detailed data showing its radioligand therapy Pluvicto could slow the progression of certain hormone-sensitive prostate cancers ahead of a planned application with the FDA. | ...

Managing prostate cancer still begins at your doctor's office, but today we know that when it comes to treating and preventing disease, nutrition plays a role. Research confirms an association ...

Stephen Freedland, MD, of Cedars-Sinai, discussed enzalutamide and leuprolide's potential to improve overall survival without ...